Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Common cold wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Sociality and disease transmission wikipedia , lookup
Transmission (medicine) wikipedia , lookup
Hospital-acquired infection wikipedia , lookup
Hepatitis C wikipedia , lookup
Human cytomegalovirus wikipedia , lookup
Marburg virus disease wikipedia , lookup
West Nile fever wikipedia , lookup
Neonatal infection wikipedia , lookup
RAPID RESPONSE TO Morris JK et al, BMJ, 2016 Sep 13 “Prevalence of microcephaly in Europe: population-based study” CONGENITAL ZIKA SYNDROME: TIME TO HARNESS SHARED DATA CENTRALIZED IN AN INTERNATIONAL REGISTRY David Baud1, Patrick Gerardin2, Audrey Merriam3, Marco P. Alves4, Didier Musso5, Blaise Genton6, Alice Panchaud7 1 Materno-fetal and Obstetrics Research Unit, Department "Femme-Mère-Enfant", University Hospital, 1011 Lausanne, Switzerland; Institute of Microbiology, Faculty of Biology and Medicine, University of Lausanne and University Hospital, Lausanne, Switzerland Pôle Femme Mère Enfant, Centre d'Investigation Clinique (INSERM CIC1410), UM 134 PIMIT 2 "Processus Infectieux en Milieu Insulaire Tropical" (Université de La Réunion, CNRS 9192, INSERM U 1187, IRD 249), CHU Réunion, Saint Pierre, Reunion, 3 Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York USA 4 Institute of Virology and Immunology, Department of Infectious Diseases and Pathobiology, University of Bern, Switzerland Unit of Emerging Infectious Diseases, Institut Louis Malardé, Tahiti, French Polynesia 5 6 Swiss Tropical and Public Health Institute, Basel, Switzerland; Infectious Disease Service and Department of Ambulatory Care, University Hospital Lausanne, Lausanne, Switzerland 7 Swiss Teratogen Information Service, University Hospital, 1011 Lausanne, Switzerland; Division of Clinical Pharmacology, University Hospital, 1011 Lausanne, Switzerland; School of Pharmaceutical Sciences, University of Geneva and Lausanne, Geneva, Switzerland; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. We welcome the paper by JK Morris et al. that emphasized the importance of congenital anomaly surveillance systems providing accurate baseline estimates essential to detect new teratogens in a timely manner [1]. The presented descriptive study highlights the critical task of measuring variation in prevalence of rare events, such as microcephaly, even when harnessing pooled data from registries covering births from a large population. In the study, substantial variability was observed between the participating registries’ estimates. This fact coupled with the rarity of the congenital anomaly studied leads to a lack of power to detect smaller variation in prevalence. Pitfalls such as heterogeneity among registries in the definition of the event of interest or ascertainment procedures were pinpointed as causes. The authors stated that increases in prevalence of microcephaly such as expected in Zika virus (ZIKV) in a non-endemic region would be unlikely to be detected in Europe through routine surveillance. Beyond the potential lack of detection power by the existing surveillance systems raised by EUROCAT contributors, to tackle the ZIKV situation, it’s time to move to the next step. Thus, as a newly identified teratogen, ZIKV requires global and dedicated tools to allow a comprehensive characterization of the risks associated to its materno-fetal transmission. Nearly a year after the first reported increase in incidence of microcephaly in Brazil [2], the magnitude of the risks of materno–fetal transmission and its associated potential cofactors remain unclear. Several possible risk factors, such as symptomatic maternal infection, gestational age at onset of infection, cross-reactive dengue antibodies or previous Herpes simplex 2 virus infection have been brought forward by the scientific community and need to be evaluated [3- 6]. Beyond these easily measurable exposures, the topic deserves even higher attention towards the exploration of the whole "fetal exposome", including maternal exposures to environmental pollutants known to be associated with low-magnitude risks, which requires larger populations to be studied. Moreover, the range of fetal and neonatal anomalies that may compose the spectrum of the congenital Zika syndrome remains to be defined. Even though microcephaly has become a central component of this syndrome [7], additional malformations have been reported [8], which enlarges considerably the range of the presumed spectrum and requires further investigation. Case reports and congenital anomaly surveillance systems are indispensable tools to detect new teratogens and have proven to be effective during the ZIKV outbreak in Brazil. However, since these tools will not likely provide global information and allow an in-depth comprehension of the association between a teratogen and its risks, epidemiological studies, such as case-control studies and cohort studies with appropriate follow-up are required. In order to facilitate these studies, we have launched an international web registry [9], enrolling prospectively and anonymously pregnant women at any gestational age as soon as a ZIKV exposure is suspected (i.e., mosquito bite, unprotected sexual intercourse, or other) and ideally before any additional screening (i.e., a prospective registry). Follow-up information on other risk factors and pregnancy, fetal, and neonatal outcomes is gathered after birth. Any healthcare provider supporting the registry by providing well documented exposures will be regarded as a collaborator of the registry in any future peer-reviewed scientific publication (information and login request for the registry at https://epgl.unige.ch/zika-in-pregnancy-registry/). The collected data will be available to any research group provided that they have a clear, nonredundant research question and approval from a biomedical research ethics committee. We hope that this centralized dataset of shared information will allow research to move to the next step in acquiring a comprehensive characterization of the risks associated to ZIKV maternofetal transmission. REFERENCES 1. Morris JK, Rankin J, Garne E, et al. Prevalence of microcephaly in Europe: population-based study." BMJ 2016; 354: i4721. 2. Kleber de Oliveira W, Cortez-Escalante K, Gonçalves Holanda de Oliveira, et al. Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy - Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016; 65: 242-7. 3. Freitas AR, Napimoga MH, Donalisio MR. Could clinical symptoms be a predictor of complications in Zika virus infection? Lancet 2016; 388: 338. 4. Panchaud A, Stojanov M, Ammerdorfffer A, Vouga M, Baud D. 2016. Emerging role of Zika virus in adverse fetal and neonatal outcomes. Clin Microbiol Rev 2016; 29: 659-94. 5. Priyamvada L, Quicke KM, Hudson WH, et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acas Sci U S A 2016; 113: 7852-7. 6. Aldo P, You Y, Szigeti K, Horvath TL, Lindenbach B, Mor G. HSV-2 enchances ZIKV infection of the placenta and induces apoptosis in first-trimester trophoblast cells. Am J Reprod Immunol 2016 Sep 10. doi: 10.1111/aji.12578 [Epub ahead of print]. 7. Araújo TVB, Rodrigues LC, Ximenes RAA, et al. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. Lancet Infect Dis 2016 Sep 15. http://dx.doi.org/10.1016/S1473-3099(16)30318-8. 8. Vouga M, Baud D. Imaging of congenital Zika virus infection: the route to identification of prognostic factors. Prenatal Diagn 2016; 36: 799-811. 9. Panchaud A, Vouga M, Musso D. Baud D. An international registry for women exposed to Zika virus during pregnancy: time for answers. Lancet ID 2016;9: 995–996.